NICE backs three hepatitis C meds, turns down Duchenne drug

NICE backs three hepatitis C meds, turns down Duchenne drug
NHS England set up a £190m fund in June to help make the drugs available for very sick HCV patients with cirrhosis of the liver, while some patients have also been eligible for treatment since 2014 thanks to funding from the Early Access Scheme …
Read more here.

Curing Hep C Lowers Risk of Death in Those Coinfected With HIV
People coinfected with HIV and hepatitis C virus (HCV) have a much lower risk of death after being cured of hep C, aidsmap reports. Researchers from the COHERE Hepatitis Subgroup, which studied hep C treatment effects among 3,500 coinfected people, …
Read more here.

Medication Adherence Trial In Hepatitis C Patients Launched
HCV therapy has been revolutionized by recent developments in treatments, including oral options that achieve high levels of HCV cure when taken as directed. That means medication adherence is a high priority for both healthcare providers and payers, …
Read more here.


Leave a Reply